Publication Name	World Journal of Gastroenterology
Manuscript ID	23558
Country	Germany

Received	2015-12-01 08:47
Peer-Review Started	2015-12-01 17:29
To Make the First Decision	2015-12-21 15:16
Return for Revision	2015-12-22 09:25
Revised	2016-01-19 03:35
Second Decision	2016-01-21 08:54
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2016-01-30 17:32
Articles in Press	2016-01-30 17:32
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2016-03-02 16:33
Publish the Manuscript Online	2016-03-23 16:22

ISSN	1007-9327 (print) and 2219-2840 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2016. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Minireviews
Article Title	Lipids in liver transplant recipients
Manuscript Source	Invited Manuscript
All Author List	Anna Hüsing, Iyad Kabar and Hartmut H Schmidt
Funding Agency and Grant Number
Corresponding Author	Hartmut H Schmidt, MD, Professor of Medicine, Department of Transplant Medicine, University Hospital Münster, Albert-Schweitzer-Campus 1, Gebäude A14, 48149 Münster, Germany. hepar@ukmuenster.de
Key Words	Liver transplantation; Dyslipidemia; Lipid management; Immunosuppression; mTOR-inhibition; Treatment
Core Tip	Lipid disorders after liver transplantation are common and can significantly increase the risk of cardiovascular events in liver transplant recipients. Furthermore, dyslipidemia may also impair graft function and survival. Therefore management of dyslipidemia is of great importance in preventing cardiovascular diseases and graft dysfunction in these patients. Knowledge of the different manifestations of lipid disorders after liver transplantation, the role of immunosuppressive agents and of drug-drug interactions is therefore essential for management and follow-up of these patients.
Publish Date	2016-03-23 16:22
Citation	Hüsing A, Kabar I, Schmidt HH. Lipids in liver transplant recipients. World J Gastroenterol 2016; 22(12): 3315-3324
URL	http://www.wjgnet.com/1007-9327/full/v22/i12/3315.htm
DOI	http://dx.doi.org/10.3748/wjg.v22.i12.3315

Full Article (PDF)	WJG-22-3315.pdf
Full Article (Word)	WJG-22-3315.doc
Manuscript File	23558-Review.docx
Answering Reviewers	23558-Answering reviewers.pdf
Audio Core Tip	23558-Audio core tip.m4a
Conflict-of-Interest Disclosure Form	23558-Conflict-of-interest statement.pdf
Copyright License Agreement	23558-Copyright assignment.pdf
Non-Native Speakers of English Editing Certificate	23558-Language certificate.pdf
Peer-review Report	23558-Peer-review(s).pdf
Scientific Misconduct Check	23558-Scientific misconduct check.pdf
Scientific Editor Work List	23558-Scientific editor work list.pdf